development-and-clinical Downloads
14 downloads found
Built on our revolutionary NxGen™ technology found in our NanoAssemblr® family of instruments, NanoAssemblr® GMP System enables you to go from concept to clinic with speed and confidence. Combined with PNI’s expertise, we accelerate the clinical and commercial development of your unique nanomedicine drug ...
The 4040 Power Back Exam Chair Series are products of extensive research and clinical feedback, developed to improve patient care and streamline the work of healthcare providers. Designed for exams, these chairs meet ADA and U.S. Access Board regulations and accommodates the needs of most ...
The 4011 Leg-Centric Procedure Chair Series are products of extensive research and clinical feedback, developed to improve patient care and streamline the work of healthcare providers, such as OB/GYN and Oncology professionals. Designed for procedures, these chairs meet ADA and U.S. Access Board regulations and accommodates the needs of most patients. ...
The NanoAssemblr® Blaze allows rapid scaling of nanoparticle formulations for late pre-clinical development. The system can manufacture between 10 mL and 10 L of formulation which allows researchers to use the Blaze for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) ...
The NextSeq 550Dx instrument is FDA regulated and CE-in vitrodiagnostic (IVD) marked, enabling clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using targeted panels, to clinical research applications that include methods from targeted panels to whole ...
BriaCell Therapeutics Corp. is a clinical stage immunotherapy company developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous ...
An enterprise-level clinical supplies management technology; Developed, supported, and maintained by customer-obsessed endpoint professionals; Inspired by client needs for supplies management in IRT & non-IRT studies; Makes complex tasks (e.g., drug pooling, reconciliation) simple; Improves product expiry management with brite stock inventory and just-in-time labeling/packaging capabilities; ...
Avioq, a trusted clinical diagnostics company, has developed a broad line of diagnostics in-vitro assays for the clinical lab. With this experience, we offer extensive contract development and manufacturing ...
The 4010 Head-Centric Procedure Chair Series are products of extensive research and clinical feedback, developed to improve patient care and streamline the work of healthcare providers, such as ENT, Dermatology, and Plastic Surgery professionals. Designed for head-centric procedures, these chairs meet ADA and U.S. Access Board regulations and accommodates the needs of most ...
Orthoforge, Inc. is a pre-clinical development stage medical device company that is combining ultrasoundbased signals with advanced data analysis, telemedicine and artificial intelligence to measure bone and soft tissue healing following an injury. We are developing a 21st century solution for bone and soft tissue healing analysis via ...
Coronaviruses belong to a large family of potentially harmful RNA viruses. In humans, they are known to be involved mainly in respiratory infections ranging from the common colds to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The recently discovered coronavirus, SARS-CoV-2, causes coronavirus disease COVID-19, a significant ...
Immunogenicity assays play a vital role in evaluating the safety and efficacy of vaccines by measuring the immune response induced in vaccinated individuals, and serve as crucial tools in vaccine development, clinical trials, licensure, and post-marketing surveillance. Various methods are employed in vaccine immunogenicity assays, ranging from traditional techniques like LBAs to advanced ...
Orthocell’s Ortho-ATI™ is a cell therapy for treatment of chronic degenerative tendon injuries. Ortho-ATI™ addresses a significant unmet clinical need for a non-surgical solution for a debilitating injury affecting millions of people every year. Ortho-ATI™ addresses the underlying pathology of tendon injury, replenishing degenerative tissue with healthy mature tendon ...
With the EU In Vitro Diagnostic Medical Devices Regulation (IVDR) becoming applicable in May 2022, the European Bioanalysis Forum, as many others, is looking at the impact of this regulation on (bio)pharmaceutical drug research and development. Already, we observe a growing concern of the industry on potential scope creep of the IVDR into early clinical studies for assets where it is believed the ...